Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Ophthalmic Goods · Vaughan, ON · filing with the SEC since 2021
Grade4.9
◀ Past 5.8● Present 5.2▶ Future 3.7
Who owns Bausch + Lomb Corporation
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
20
report now, of 26 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What BLCO reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Bhc
An entity · legal entity · owns, named in the 10-K filed Feb 18, 2026
Manufacturing Equipment
A company bought · acquisition · Nov 2025 · owns, named in the 10-K filed Feb 18, 2026
Elios Vision Acquisition
A company bought · acquisition · Nov 2024 · owns, named in the 10-K filed Feb 18, 2026
Trukera Medical
A company bought · acquisition · Jul 2024 · owns, named in the 10-K filed Feb 18, 2026
XIIDRA Acquisition
A company bought · acquisition · Sep 2023 · owns, named in the 10-K filed Feb 18, 2026
AcuFocus, Inc. Acquisition
A company bought · acquisition · Jan 2023 · owns, named in the 10-K filed Feb 18, 2026
83 subsidiaries in 41 countries, from the list filed with the 10-K filed Feb 18, 2026.
Insider tradesForm 4
4sales
9purchases
0sales on a scheduled plan
2people selling
$3.5Msold, in dollars
$1.2Mbought, in dollars
Open-market trades on Form 4 from Nov 2, 2025 to Nov 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window10 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Munsch Frederick | SVP, Controller and CAO | 2 | $3.2M | 0 | 0 | $0 |
| Von Eschenbach Andrew C. | director | 2 | $300,000 | 0 | 1 | $100,000 |
| Saunders Brent L | Chairman of the Board and CEO | 0 | $0 | 0 | 1 | $300,000 |
| Eldessouky Sam | EVP and CFO | 0 | $0 | 0 | 1 | $100,000 |
| Bailey A Robert D | EVP & Chief Legal Officer | 0 | $0 | 0 | 1 | $300,000 |
| Alfonso Eduardo | director | 0 | $0 | 0 | 1 | $100,000 |
| Robertson Russel C | director | 0 | $0 | 0 | 1 | $100,000 |
| Collis Steven H | director | 0 | $0 | 0 | 1 | $300,000 |
| Ling Karen | director | 0 | $0 | 0 | 1 | $100,000 |
| Ross Thomas W. Sr. | director | 0 | $0 | 0 | 1 | $100,000 |